☆ 4.7 Article

On-demand integrated nano-engager converting cold tumors to hot via increased DNA damage and dual immune checkpoint inhibition

ACTA PHARMACEUTICA SINICA B (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Multidisciplinary

A Photosensitizer Discretely Loaded Nanoaggregate with Robust Photodynamic Effect for Local Treatment Triggers Systemic Antitumor Responses

Hao Zhao et al.

Summary: This study demonstrates a strategy to enhance the efficacy of photodynamic therapy (PDT) by optimizing the aggregation degree of indocyanine green (ICG) nanoaggregates. The improved PDT efficacy promotes immunogenic cell death (ICD) and systemic antitumor responses via local treatment.

ACS NANO (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer

Xinyun Qiu et al.

Summary: ATN-MPTX, constructed with the clinically validated ATN peptide as a ligand and reduction-sensitive biodegradable micelles as a vehicle, demonstrates strong and selective induction of ICD and chemo-immunotherapy for TNBC, showing superior tumor accumulation and treatment efficacy compared to controls in therapeutic studies.

JOURNAL OF CONTROLLED RELEASE (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Photothermal/matrix metalloproteinase-2 dual-responsive gelatin nanoparticles for breast cancer treatment

Xiaojie Chen et al.

Summary: In this study, nanoparticles with dual-responsive, tumor targeting characteristics were designed for the treatment of breast cancer through the combination of photothermal therapy and chemotherapy. The variability in nanoparticle size and characteristics enhanced drug release and therapeutic efficacy against breast cancer.

ACTA PHARMACEUTICA SINICA B (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Immunogenic Hybrid Nanovesicles of Liposomes and Tumor-Derived Nanovesicles for Cancer Immunochemotherapy

Mei Hu et al.

Summary: Researchers have developed a novel hybrid nanovesicle that combines chemotherapy drugs with immunotherapy, targeting tumor tissue and triggering an effective immunogenic cell death response, thus activating the immune system and enhancing tumor immunogenicity.

ACS NANO (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Nano-immunotherapy: Unique mechanisms of nanomaterials in synergizing cancer immunotherapy

Quan Liu et al.

Summary: Therapeutic targeting of the immune system, including immunotherapy and nanotechnology, presents a promising approach for treating various cancers. While immunotherapeutics have limitations, nanotechnology offers unique opportunities to enhance therapeutic efficacy through precision targeting and controlled drug release. Combining these two modalities could provide synergistic efficacy in cancer treatment.

NANO TODAY (2021)

添加到收藏夹

Article Nanoscience & Nanotechnology

Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection

Jing Zhang et al.

Summary: The study introduces an injectable hydrogel system that stimulates tumoricidal immunity after GBM surgical resection, effectively reducing its recurrence. This system induces immunogenic cell death and sustained T-cell infiltration to attack residual tumor cells, significantly suppressing postoperative GBM recurrence.

NATURE NANOTECHNOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

The injury response to DNA damage in live tumor cells promotes antitumor immunity

Ganapathy Sriram et al.

Summary: Creating a live, injured tumor cell adjuvant through DNA damage enhances the efficacy of immune checkpoint blockade treatment, offering a strategy to improve the therapeutic effects on tumor types that do not respond to ICB alone.

SCIENCE SIGNALING (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Application of immune checkpoint targets in the anti-tumor novel drugs and traditional Chinese medicine development

Yuli Wang et al.

Summary: Immune checkpoints are crucial regulators of the immune system, with traditional Chinese medicines having the advantage of containing multiple active components that can act on multiple targets simultaneously, potentially producing additive or synergistic effects in cancer treatment.

ACTA PHARMACEUTICA SINICA B (2021)

添加到收藏夹

Review Nanoscience & Nanotechnology

Recent Advancements in Nanomedicine for 'Cold' Tumor Immunotherapy

Qinjun Chen et al.

Summary: Despite the high clinical success rate of current anticancer immunotherapies using immune check-point inhibitors (ICIs), many patients with 'cold' tumors still respond poorly to ICI therapy due to insufficient T cell infiltration and low immunogenicity. Advances in precision medicine and nanotechnology have shown promise in improving treatment for these patients by targeting the immunosuppressive tumor immune microenvironment in cold tumors.

NANO-MICRO LETTERS (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR

Xiaojia Liu et al.

Summary: TBM-1 negatively regulates PD-L1 level, disrupts PD-1/PD-L1 interaction, and activates tumor-infiltrating T-cell immunity in mice models. Mechanistically, TBM-1 triggers PD-L1 lysosomal degradation in a TFEB-dependent pathway, inhibits mTORC1 activation, and enhances antitumor T-cell immunity in combination with anti-CTLA-4.

ACTA PHARMACEUTICA SINICA B (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy

Jiwoong Choi et al.

Summary: Immune checkpoint blockade is a promising approach for cancer immunotherapy, but many patients do not respond due to the immunosuppressive tumor microenvironment. This study proposes visible-light-triggered prodrug nanoparticles (LT-NPs) to reverse the immunosuppressive tumor microenvironment and enhance checkpoint blockade immunotherapy, showing promising results in tumor models.

ACS NANO (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

An Integrated Nanoaircraft Carrier Modulating Antitumor Immunity to Enhance Immune Checkpoint Blockade Therapy

Shuang Liang et al.

Summary: This study introduces an integrated nanoaircraft carrier loaded with three therapeutic agents to target tumor cells, enhance T-cells infiltration, and reverse the immunosuppressive microenvironment.

ADVANCED FUNCTIONAL MATERIALS (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Manipulation of TAMs functions to facilitate the immune therapy effects of immune checkpoint antibodies

Yang Liu et al.

Summary: Manipulation of tumor-associated macrophages (TAMs) has been identified as a key factor in improving immunotherapies, with inhibition of the NF-kappa B pathway potentially impacting both PD-1/PD-L1 and NF-kappa B pathways simultaneously. Co-loading PD-1 antibody and NF-kappa B pathway inhibitor in nanocarriers has shown promising results in enhancing the efficacy of immunotherapies.

JOURNAL OF CONTROLLED RELEASE (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Overcoming Chemoimmunotherapy-Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension

Seung Mo Jin et al.

Summary: A novel immune modulating suspension containing inducers of cell death and supra-adjuvants can effectively increase cytotoxic T lymphocytes and alleviate immune suppression in the tumor microenvironment, leading to enhanced T cell infiltration and inhibition of tumor metastasis. This approach shows promise in increasing the response rate of immune checkpoint blockade therapy, presenting a new nanotheranostic strategy in cancer immunotherapy.

ADVANCED SCIENCE (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver Metastasis

Jianfeng Guo et al.

ACS NANO (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

The progress and perspective of nanoparticle-enabled tumor metastasis treatment

Wei Zhang et al.

ACTA PHARMACEUTICA SINICA B (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Trap and kill strategy for non-BRCA mutant pancreatic cancer by co-delivery of olaparib and JQ1 with plectin-1 targeting peptide nanoparticles

Yazhou Wang et al.

NANO TODAY (2020)

添加到收藏夹

Review Oncology

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Lorenzo Galluzzi et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity

Jingjing Liang et al.

SCIENCE ADVANCES (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy

Yuefei Zhu et al.

ACTA PHARMACEUTICA SINICA B (2020)

添加到收藏夹

Review Immunology

TIM3 comes of age as an inhibitory receptor

Yochai Wolf et al.

NATURE REVIEWS IMMUNOLOGY (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Tumors and Their Microenvironment Dual-Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer

Caifeng Deng et al.

ADVANCED SCIENCE (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1

Hairui Wang et al.

NANO LETTERS (2019)

添加到收藏夹

Article Nanoscience & Nanotechnology

Promoting Early Diagnosis and Precise Therapy of Hepatocellular Carcinoma by Glypican-3-Targeted Synergistic Chemo-Photothermal Theranostics

Weiwei Mu et al.

ACS APPLIED MATERIALS & INTERFACES (2019)

添加到收藏夹

Review Oncology

Combination of CTLA-4 and PD-1 blockers for treatment of cancer

Anand Rotte

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Article Nanoscience & Nanotechnology

JQ1-Loaded Polydopamine Nanoplatform Inhibits c-MYC/Programmed Cell Death Ligand 1 to Enhance Photothermal Therapy for Triple-Negative Breast Cancer

Ying Tian et al.

ACS APPLIED MATERIALS & INTERFACES (2019)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Jerome Galon et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade

Fangyuan Zhou et al.

ADVANCED MATERIALS (2019)

添加到收藏夹

Review Immunology

Cold Tumors: A Therapeutic Challenge for Immunotherapy

Paola Bonaventura et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles

Fred C. Lam et al.

NATURE COMMUNICATIONS (2018)

添加到收藏夹

Review Medicine, Research & Experimental

Emerging strategies for combination checkpoint modulators in cancer immunotherapy

Aleksandra Popovic et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

BRD4 and Cancer: going beyond transcriptional regulation

Benedetta Donati et al.

MOLECULAR CANCER (2018)

添加到收藏夹

Article Oncology

Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration

Ayman Oweida et al.

CLINICAL CANCER RESEARCH (2018)

添加到收藏夹

Review Immunology

Tim-3 and its role in regulating anti-tumor immunity

Madhumita Das et al.

IMMUNOLOGICAL REVIEWS (2017)

添加到收藏夹

Review Cell Biology

The multifaceted roles of PARP1 in DNA repair and chromatin remodelling

Arnab Ray Chaudhuri et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)

添加到收藏夹

Article Chemistry, Multidisciplinary

Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy

Bo Zhang et al.

JOURNAL OF CONTROLLED RELEASE (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

Shohei Koyama et al.

NATURE COMMUNICATIONS (2016)

添加到收藏夹

Article Cell Biology

BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression

Hengrui Zhu et al.

CELL REPORTS (2016)

添加到收藏夹

Review Oncology

DNA damage and the balance between survival and death in cancer biology

Wynand P. Roos et al.

NATURE REVIEWS CANCER (2016)

添加到收藏夹

Article Oncology

Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma

Oumou Goundiam et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

添加到收藏夹

Article Chemistry, Multidisciplinary

Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin

Leila Arabi et al.

JOURNAL OF CONTROLLED RELEASE (2015)

添加到收藏夹

Article Oncology

BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy

Miguel F. Segura et al.

CANCER RESEARCH (2013)

添加到收藏夹

Article Multidisciplinary Sciences

The bromodomain protein Brd4 insulates chromatin from DNA damage signalling

Scott R. Floyd et al.

NATURE (2013)

添加到收藏夹

Review Oncology

Cancer immunotherapy via dendritic cells

Karolina Palucka et al.

NATURE REVIEWS CANCER (2012)

添加到收藏夹

Review Oncology

The blockade of immune checkpoints in cancer immunotherapy

Drew M. Pardoll

NATURE REVIEWS CANCER (2012)

添加到收藏夹

Article Oncology

Anti-TIM3 Antibody Promotes T Cell IFN-γ-Mediated Antitumor Immunity and Suppresses Established Tumors

Shin Foong Ngiow et al.

CANCER RESEARCH (2011)

添加到收藏夹

Article Immunology

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

Kaori Sakuishi et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

添加到收藏夹

Article Multidisciplinary Sciences

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

Michael A. Curran et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.